Amplifon S.p.A ROE 2019-2025 | AMFPF
Current and historical return on equity (ROE) values for Amplifon S.p.A (AMFPF) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Amplifon S.p.A ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-03-31 | $0.14B | $1.20B | 11.84% |
| 2024-03-31 | $0.13B | $1.24B | 11.75% |
| 2023-03-31 | $0.10B | $1.12B | 10.00% |
| 2022-03-31 | $0.09B | $1.10B | 9.92% |
| 2021-03-31 | $0.10B | $1.00B | 13.06% |
| 2020-03-31 | $0.09B | $0.74B | 16.16% |
| 2019-03-31 | $0.12B | $0.71B | 34.13% |
| 2018-12-31 | $0.12B | $0.70B | 67.61% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $3.508B | $2.607B |
| Amplifon SpA provides hearing solutions and services. It operates principally in Italy, France, Spain, Portugal, Switzerland, Austria, Holland, the United States, Hungary and Egypt. Amplifon SpA is based in Milan, Italy. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $159.868B | 29.35 |
| HCA Healthcare (HCA) | United States | $110.622B | 18.31 |
| CVS Health (CVS) | United States | $100.818B | 11.59 |
| Elevance Health (ELV) | United States | $79.799B | 11.70 |
| Cencora (COR) | United States | $67.122B | 21.64 |
| Natera (NTRA) | United States | $32.084B | 0.00 |
| DiDi Global (DIDIY) | China | $23.674B | 21.87 |
| Labcorp Holdings (LH) | United States | $21.901B | 16.70 |
| Medpace Holdings (MEDP) | United States | $15.715B | 39.01 |
| ICON (ICLR) | Ireland | $15.068B | 14.95 |
| BioMerieux (BMXMF) | France | $14.825B | 0.00 |
| Solventum (SOLV) | United States | $14.393B | 13.97 |
| Viatris (VTRS) | United States | $13.418B | 5.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.123B | 0.00 |
| CochLear (CHEOY) | Australia | $11.455B | 0.00 |
| Revvity (RVTY) | United States | $11.393B | 20.98 |
| Charles River Laboratories (CRL) | United States | $9.500B | 18.30 |
| HealthEquity (HQY) | United States | $8.269B | 30.92 |
| Sonic Healthcare (SKHHY) | Australia | $7.631B | 0.00 |
| Avantor (AVTR) | United States | $7.616B | 11.64 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.550B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $6.590B | 39.29 |
| Bausch + Lomb (BLCO) | Canada | $6.018B | 39.51 |
| PACS (PACS) | United States | $5.449B | 33.13 |
| Sotera Health (SHC) | United States | $4.781B | 23.06 |
| GeneDx Holdings (WGS) | United States | $4.379B | 76.91 |
| Alignment Healthcare (ALHC) | United States | $3.874B | 0.00 |
| Concentras Parent (CON) | United States | $2.547B | 15.90 |
| Progyny (PGNY) | United States | $2.303B | 45.27 |
| Establishment Labs Holdings (ESTA) | United States | $2.107B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.022B | 26.05 |
| Pediatrix Medical (MD) | United States | $1.932B | 11.54 |
| Organon (OGN) | United States | $1.864B | 1.96 |
| Teladoc Health (TDOC) | United States | $1.340B | 0.00 |
| Nutex Health (NUTX) | United States | $1.308B | 10.00 |
| Ardent Health (ARDT) | United States | $1.259B | 4.11 |
| CareDx (CDNA) | United States | $1.057B | 17.28 |
| GoodRx Holdings (GDRX) | United States | $0.957B | 15.67 |
| Omada Health (OMDA) | $0.874B | 0.00 | |
| InnovAge Holding (INNV) | United States | $0.733B | 0.00 |
| Embecta (EMBC) | United States | $0.690B | 3.97 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.647B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.582B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| Enhabit (EHAB) | United States | $0.490B | 22.00 |
| CryoPort (CYRX) | United States | $0.471B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.442B | 0.00 |
| SBC Medicals (SBC) | United States | $0.429B | 7.89 |
| Oncology Institute (TOI) | United States | $0.372B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.338B | 5.43 |
| QDM (QDMI) | Hong Kong, SAR China | $0.323B | 67.42 |
| So-Young (SY) | China | $0.312B | 0.00 |
| Agilon Health (AGL) | United States | $0.298B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.296B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.188B | 0.00 |
| Beauty Health (SKIN) | United States | $0.179B | 0.00 |
| KindlyMD (NAKA) | United States | $0.176B | 0.00 |
| LifeMD (LFMD) | United States | $0.164B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.135B | 0.00 |
| DocGo (DCGO) | United States | $0.090B | 0.00 |
| Biodesix (BDSX) | United States | $0.062B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.057B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.046B | 0.00 |
| Pomdoctor - (POM) | China | $0.043B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.033B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.021B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.24 |
| Basel Medical Group (BMGL) | Singapore | $0.017B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.016B | 0.00 |
| Lifeward (LFWD) | United States | $0.012B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.005B | 0.00 |
| XWELL (XWEL) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |